30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Peter Ordentlich

Track

Insider profile

Currently holds a position at Syndax Pharmaceuticals Inc

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 4% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Scientific Officer Syndax Pharmaceuticals Inc Sept. 1, 2016 -
Chief Technology Officer Syndax Pharmaceuticals Inc Nov. 1, 2013 - Sept. 1, 2016
Vice President of Translational Medicine, Founder Syndax Pharmaceuticals Inc Jan. 1, 2012 - Oct. 1, 2013
Peter Ordentlich's trades of Syndax Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-02-17 2023-02-15
PlS Planned sale
51,933 -30.2%
288.55
US$4,424,594 		51,933 -30.2% 288.55 US$4,424,594
2023-02-17 2023-02-15
PlS Planned sale
81,066 -34.3%
431.46
US$2,573,307 		81,066 -34.3% 431.46 US$2,573,307
2023-02-03 2023-02-01
S Sale
26,333 +29.6%
193.03
US$109,416 		26,333 +29.6% 193.03 US$109,416
2022-12-02 2022-12-02
PlS Planned sale
17,200 -98.5%
25.05
US$430,936 		17,200 -98.5% 25.05 US$430,936
2022-12-02 2022-12-01
PlS Planned sale
4,028 -93.8%
25.01
US$100,746 		4,028 -93.8% 25.01 US$100,746
2022-12-02 2022-12-01
PlS Planned sale
3,772 -93.4%
25.01
US$94,343 		3,772 -93.4% 25.01 US$94,343
2022-08-26 2022-08-24
PlS Planned sale
2,154 -89.0%
25.04
US$53,927 		2,154 -89.0% 25.04 US$53,927
2022-08-26 2022-08-24
PlS Planned sale
22,846 -98.9%
25.04
US$571,966 		22,846 -98.9% 25.04 US$571,966
2022-02-03 2022-02-01
S Sale
1,412 -100.0%
16.65
US$23,510 		1,412 -100.0% 16.65 US$23,510
2020-11-25 2020-11-23
S Sale
16,334 -100.0%
22.89
US$373,924 		16,334 -100.0% 22.89 US$373,924
2020-11-25 2020-11-23
S Sale
7,954 -32.7%
23.58
US$187,594 		7,954 -32.7% 23.58 US$187,594
2020-11-25 2020-11-23
S Sale
5,684 -19.0%
23.33
US$132,603 		5,684 -19.0% 23.33 US$132,603